Journal
JOURNAL OF PROTEOME RESEARCH
Volume 11, Issue 2, Pages 576-585Publisher
AMER CHEMICAL SOC
DOI: 10.1021/pr200777u
Keywords
ion mobility; ESI mass spectrometry; glycans; cancer; principal component analysis
Categories
Funding
- National Center for Glycomics and Glycoproteomics (NCGG) through the National Institute of Health (NIH) within the National Center for Research Resources (NCRR) [RR018942]
- NCI [R03 CA119288, R01 CA115625-01A2]
Ask authors/readers for more resources
Altered branching and aberrant expression of N-linked glycans is known to be associated with disease states such as cancer. However, the complexity of determining such variations hinders the development of specific glycomic approaches for assessing disease states. Here, we examine a combination of ion mobility spectrometry (IMS) and mass spectrometry (MS) measurements, with principal component analysis (PCA) for characterizing serum N-linked glycans from 81 individuals: 28 with cirrhosis of the liver, 25 with liver cancer, and 28 apparently healthy. Supervised PCA of combined ion-mobility profiles for several, to as many as 10 different mass-to-charge ratios for glycan ions, improves the delineation of diseased states. This extends an earlier study [J. Proteome Res. 2008, 7, 1109-1117] of isomers associated with a single glycan (S1H5N4) in which PCA analysis of the IMS profiles appeared to differentiate the liver cancer group from the other samples. Although performed on a limited number of test subjects, the combination of IMS-MS for different combinations of ions and multivariate PCA analysis shows promise for characterizing disease states.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available